Does raloxifene reduce breast cancer risk?
Mattimoe
D
D
University of North Carolina, Chapel Hill, USA.
Newton
W
W
D000368:Aged; D001943:Breast Neoplasms / Q000453:epidemiology / Q000517:prevention & control*; D004311:Double-Blind Method; D004965:Estrogen Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D015914:Estrogen Replacement Therapy; D005260:Female; D006801:Humans; D015994:Incidence; D010880:Piperidines / Q000009:adverse effects / Q000627:therapeutic use*; D017698:Postmenopause; D020849:Raloxifene Hydrochloride; D012307:Risk Factors
D004965:Estrogen Antagonists; D010880:Piperidines; D020849:Raloxifene Hydrochloride